Mit Magzter GOLD unbegrenztes Potenzial nutzen

Mit Magzter GOLD unbegrenztes Potenzial nutzen

Erhalten Sie unbegrenzten Zugriff auf über 9.000 Zeitschriften, Zeitungen und Premium-Artikel für nur

$149.99
 
$74.99/Jahr

Versuchen GOLD - Frei

There's crushing news for people who want to live long

Mint Bangalore

|

April 21, 2025

A wonder drug that a wealthy longevity seeker was testing on himself may have turned out to be a dud

- MANU JOSEPH

A few days ago, Bryan Johnson, a centi-millionaire who has spent millions on reversing ageing—especially his own—posted some bad news for humanity on his YouTube channel. Rapamycin, which for a long time has been the most promising molecule in our quest to prolong youth, was not making him younger; instead, it was "accelerating" his ageing.

Johnson, who is 47 and looks 46, conducts various experiments on himself in his effort to live like a young man for a very long time. I am counting on him. His food consumption is so calibrated that he knows the number of calories he has gulped. He does not eat after 11 am, unless he has to meet people socially and must eat at ungodly hours like 7 pm just to shut them up. He sleeps around 8:30 pm, alone. I know he has high standards for himself because he recently visited Delhi, probably out of ignorance, and refused to breathe the air for too long. Among the most important things he was performing on himself was taking small quantities of rapamycin, a drug that is chiefly used to prevent the body's rejection of organ transplants. It does not have approval as an anti-ageing drug, though it is widely believed to have potential for that. The compound had extended the lifespan of mice and worms beyond ambiguity, and of other animals, too. Johnson was its most famous human test subject.

WEITERE GESCHICHTEN VON Mint Bangalore

Mint Bangalore

Mint Bangalore

SMALL STAYS, BIG MARGINS: INSIDE MMT'S PIVOT

MakeMyTrip is leaning on 'constructive paranoia' to counter rivals and the threat of direct booking

time to read

7 mins

October 24, 2025

Mint Bangalore

Mint Bangalore

Infosys promoters are opting out of its buyback due to tax

The decision of Infosys Ltd's promoters to opt out of its largest buyback of ₹18,000 crore points to an underlying concern: tax.

time to read

2 mins

October 24, 2025

Mint Bangalore

Mint Bangalore

Steelmakers battle low prices as demand slips, stocks grow

Prices of steel used in cars and home appliances have fallen to a nine-month low in India and that used in construction and infrastructure to a near-five-year low with no clear path to recovery in sight.

time to read

2 mins

October 24, 2025

Mint Bangalore

Mint Bangalore

Torrent to proceed with bond sale plans

India's Torrent Pharmaceuticals will proceed with its plan to sell bonds worth as much as ₹14,000 crore ($1.6 billion) after the country's competition regulator approved its acquisition of JB Chemicals & Pharmaceuticals earlier this

time to read

1 min

October 24, 2025

Mint Bangalore

Mint Bangalore

Accenture leads race for IIM talent as clients navigate Al

Consulting firms accounted for a record 46% offers at IIM Bangalore summer placements

time to read

3 mins

October 24, 2025

Mint Bangalore

Mint Bangalore

AI workers are putting in 100-hour weeks in tech arms race

Josh Batson no longer has time for social media.

time to read

1 mins

October 24, 2025

Mint Bangalore

Srinivasan’s Tata Trusts continuity a mere formality

other trustees was already taken and approved pursuant to the aforesaid resolution of 17 October 2024 by each of the trustees and the resolution proposed in Circular No: 87 dated 18 October 2025 is a formalistic one to give effect to an already taken unanimous decision of the trustees,\" Mehli Mistry wrote in response to a circular, dated 18 October, seeking reappointment of Srinivasan.

time to read

2 mins

October 24, 2025

Mint Bangalore

Will the AI browser rush yield another AI winter?

Big Tech players are vying to change our lives with Agentic AI browsers but they might pay a heavy price if this reckless dash goes wrong, sending user trust and funding into a deep chill

time to read

2 mins

October 24, 2025

Mint Bangalore

BSE keeps its grip on options volumes despite expiry shift

Asia's oldest stock exchange has defied expectations that a shift in weekly index options expiry days would hit its volumes, instead chipping away at its rival National Stock Exchange's (NSE's) dominant market share, per early trends.

time to read

1 mins

October 24, 2025

Mint Bangalore

RBI cautions states on fiscal discipline as bond yields rise

Flagging a sharp rise in state bond yields, the Reserve Bank of India (RBI) has cautioned states against pre-election populist spending and fiscal slippage, especially in Bihar and Maharashtra.

time to read

1 min

October 24, 2025

Listen

Translate

Share

-
+

Change font size